Experic
Cranbury, US · Delaware LLC · 1 known investors
Find your way into Experic
Sign up to see every warm intro you have to Experic
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Experic team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Experic is a CDMO (Contract Development and Manufacturing Organization) specializing in inhalation pharmaceutical product development, formulation engineering, and clinical manufacturing services. The company provides process development, analytical testing, technology transfer, and scale-up support for inhalation drugs and encapsulated solid dose pharmaceuticals.
Founders & leadership

Board

Investors · 1
How we know: 1315 Capital's portfolio page · press coverage · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$15M disclosed across 1 of 3 rounds · 2022–2024
- Undisclosed amountSeries B ExtensionOct 2023 · 2 sourcesSource ↗
- Undisclosed amountSeries BDec 2022Source ↗
▶$15MraisedMay 2025 · 8 investors · OtherRule 506(b)
- Thomas WellerDirector
- Derek HenneckeDirector
- William MitchellDirector
- Andrew FrazierDirector
- Matthew ReberDirector
- David WoodExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Sep 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Experic.
In the news
Frequently asked questions
- What does Experic do?
- Experic is a CDMO (Contract Development and Manufacturing Organization) specializing in inhalation pharmaceutical product development, formulation engineering, and clinical manufacturing services. The company provides process development, analytical testing, technology transfer, and scale-up support for inhalation drugs and encapsulated solid dose pharmaceuticals.
- Who are Experic's investors?
- Experic's investors include 1315 Capital.
- How much funding has Experic raised?
- Experic has disclosed $15M raised across 1 of its 3 known rounds.
- Where is Experic headquartered?
- Experic is headquartered in Cranbury, US.

